PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Product: Mirapexin
Presentation Product Chemical substance Chapter Items dispensed
Mirapexin 0.088mg tablets
0409010W0BBACAC
Mirapexin Pramipexole Central Nervous System 673
Mirapexin 0.18mg tablets
0409010W0BBABAB
Mirapexin Pramipexole Central Nervous System 288
Mirapexin 1.05mg modified-release tablets
0409010W0BBAGAG
Mirapexin Pramipexole Central Nervous System 228
Mirapexin 0.52mg modified-release tablets
0409010W0BBAFAF
Mirapexin Pramipexole Central Nervous System 187
Mirapexin 2.1mg modified-release tablets
0409010W0BBAHAH
Mirapexin Pramipexole Central Nervous System 173
Mirapexin 1.57mg modified-release tablets
0409010W0BBAJAJ
Mirapexin Pramipexole Central Nervous System 170
Mirapexin 0.26mg modified-release tablets
0409010W0BBAEAE
Mirapexin Pramipexole Central Nervous System 158
Mirapexin 3.15mg modified-release tablets
0409010W0BBAIAI
Mirapexin Pramipexole Central Nervous System 134
Mirapexin 0.35mg tablets
0409010W0BBADAD
Mirapexin Pramipexole Central Nervous System 124
Mirapexin 0.7mg tablets
0409010W0BBAAAA
Mirapexin Pramipexole Central Nervous System 93
Mirapexin 2.62mg modified-release tablets
0409010W0BBAKAK
Mirapexin Pramipexole Central Nervous System 79

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.